Senti Biosciences Holdings (SNTI) Asset Utilization Ratio (2022 - 2024)
Senti Biosciences Holdings (SNTI) posted quarterly Asset Utilization Ratio of 0.0 for Q2 2024, down 84.63% year-over-year from 0.02 in Q3 2023, and down 61.34% quarter-over-quarter from 0.01 in Q1 2024.
Senti Biosciences Holdings (SNTI) Asset Utilization Ratio (2022 - 2024) Analysis & Trends
Senti Biosciences Holdings' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q2 2024.
- In Q2 2024, Asset Utilization Ratio fell 84.63% year-over-year to 0.0; the TTM figure through Jun 2024 stood at 0.0 (down 84.63% YoY), while the FY2025 annual figure was 0.0, changed N/A from the prior year.
- Asset Utilization Ratio for Q2 2024 stood at 0.0, down from 0.01 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.02 in Q1 2023, with the low at 0.0 in Q2 2024.
- The 3-year median for Asset Utilization Ratio is 0.02 (2022), against an average of 0.02.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio grew 29.61% in 2023, then slumped 84.63% in 2024.
- Senti Biosciences Holdings' Asset Utilization Ratio stood at 0.02 in 2022, then slipped by 15.65% to 0.02 in 2023, then tumbled by 80.57% to 0.0 in 2024.
- Business Quant data shows SNTI's Asset Utilization Ratio at 0.0 in Q2 2024, 0.01 in Q1 2024, and 0.02 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Senti Biosciences Holdings | 12.06 Mn | 12.06 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |